Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helio Fernandes Da RochafiledCriticalHelio Fernandes Da Rocha
Priority to BR0100810-2ApriorityCriticalpatent/BR0100810A/en
Publication of BR0100810ApublicationCriticalpatent/BR0100810A/en
Coloring Foods And Improving Nutritive Qualities
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
"SISTEMA NEO - NUTRIENTE". O presente pedido de patente de uma Nova Formulação na Composição de um Suplemento Nuticional que diluído, proporcionalmente, seja ministrado por infusão única e ininterrupta de 24h. Com , a utilização de agente químico ( fosfato orgânico ) evitando a presença de precipitado que podem prejudicar o aproveitamento de algumas vitaminas lipídios"NEO - NUTRIENT SYSTEM". The present patent application for a New Formulation in the Composition of a Nutritional Supplement which, proportionally diluted, is administered by a single, uninterrupted infusion of 24 hours. With, the use of chemical agent (organic phosphate) avoiding the presence of precipitate that can impair the use of some lipid vitamins
BR0100810-2A2001-03-022001-03-02
Neo-nutrient system
BR0100810A
(en)
Uses of a nsaid that releases not as a pharmaceutically acceptable salt or enanciÈmero thereof, and of an nsaid that releases not and a proton pump inhibitor susceptible to acid or a salt thereof or an enanciancmero or an enanciÈmero salt , method for the treatment of a bacterial infection, and, pharmaceutical formulation suitable for use in the treatment of bacterial infections
Process for the manufacture of an isotretinoin composition, micronized isotretinoin composition, unit dosage form for enteral administration and pharmaceutical composition in unit form
Formulation suitable for subcutaneous administration comprising at least 100 mg / ml of ctlaig, a sugar, and a pharmaceutically stable aqueous carrier; article of manufacture comprising at least one container containing the aforementioned formulation. (divisional application n ° 3597-06)
alkaloid formulation, method for improving the effectiveness of an alkaloid, use of the reaction product of one or more alkaloids with one or more phosphate derivatives of one or more electron transfer agents, together with excipients and pharmaceutical composition
ACID DERIVATIVES 1,2,3,4-TETRAHYDROQUINOLIN-2-CARBOXILICO REPLACED, PROCEDURES FOR THEIR PREPARATION, ITS USE FOR THE PREPARATION OF MEDICINES AND MEDICINES CONTAINING THESE COMPOUNDS
Legal Events
Date
Code
Title
Description
B08E
Application fees: requirement for complementation of annuity fee
Free format text:
COMPLEMENTAR A 3A ANUIDADE REFERENTE A GUIA 300235743037 DE ACORDO COM A TABELA VIGENTE E COMPROVAR O RECOLHIMENTO DA TAXA DE RESTAURACAO DA 3A ANUIDADE.
B08G
Application fees: restoration
B15K
Others concerning applications: alteration of classification
Free format text:
ALTERADO DE A61K 9/08.
Ipc:
A23L 1/00 (2009.01)
B07A
Technical examination (opinion): publication of technical examination (opinion)
B09B
Decision: refusal
B09B
Decision: refusal
Free format text:
MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.
B15K
Others concerning applications: alteration of classification